chr2-165992194-T-C
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PM1PM2PM5PP2PP3_ModeratePP5
The NM_001165963.4(SCN1A):c.5081A>G(p.Tyr1694Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y1694F) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001165963.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SCN1A | ENST00000674923.1 | c.5081A>G | p.Tyr1694Cys | missense_variant | Exon 29 of 29 | NM_001165963.4 | ENSP00000501589.1 | |||
| SCN1A | ENST00000303395.9 | c.5081A>G | p.Tyr1694Cys | missense_variant | Exon 28 of 28 | 5 | ENSP00000303540.4 | |||
| SCN1A | ENST00000375405.7 | c.5048A>G | p.Tyr1683Cys | missense_variant | Exon 26 of 26 | 5 | ENSP00000364554.3 | |||
| SCN1A | ENST00000409050.2 | c.4997A>G | p.Tyr1666Cys | missense_variant | Exon 28 of 28 | 5 | ENSP00000386312.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy Pathogenic:1
This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 1694 of the SCN1A protein (p.Tyr1694Cys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with early infantile epileptic encephalopathy or generalized epilepsy with febrile seizures (PMID: 14738421, 19586930, 28202706). It has also been observed to segregate with disease in related individuals. This variant is also known as Tyr1684Cys. ClinVar contains an entry for this variant (Variation ID: 68650). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt SCN1A protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. -
SCN1A-related disorder Pathogenic:1
The SCN1A c.5081A>G variant is predicted to result in the amino acid substitution p.Tyr1694Cys. This variant has been reported in individuals with various epilepsy phenotypes (referred to as Y1684C, Fukuma et al. 2004. PubMed ID: 14738421; Table e-1, Cetica et al. 2017. PubMed ID: 28202706; eTable 1, Brunklaus et al. 2022. PubMed ID: 35074891). This variant has not been reported in a large population database, indicating it is rare. This variant is interpreted as likely pathogenic. -
not specified Uncertain:1
- -
Severe myoclonic epilepsy in infancy Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at